Antibiotic Therapy in the Critically Ill with Acute Renal Failure and Renal Replacement Therapy: A Narrative Review
- PMID: 36551426
- PMCID: PMC9774462
- DOI: 10.3390/antibiotics11121769
Antibiotic Therapy in the Critically Ill with Acute Renal Failure and Renal Replacement Therapy: A Narrative Review
Abstract
The outcome for critically ill patients is burdened by a double mortality rate and a longer hospital stay in the case of sepsis or septic shock. The adequate use of antibiotics may impact on the outcome since they may affect the pharmacokinetics (Pk) and pharmacodynamics (Pd) of antibiotics in such patients. Acute renal failure (ARF) occurs in about 50% of septic patients, and the consequent need for continuous renal replacement therapy (CRRT) makes the renal elimination rate of most antibiotics highly variable. Antibiotics doses should be reduced in patients experiencing ARF, in accordance with the glomerular filtration rate (GFR), whereas posology should be increased in the case of CRRT. Since different settings of CRRT may be used, identifying a standard dosage of antibiotics is very difficult, because there is a risk of both oversimplification and failing the therapeutic efficacy. Indeed, it has been seen that, in over 25% of cases, the antibiotic therapy does not reach the necessary concentration target mainly due to lack of the proper minimal inhibitory concentration (MIC) achievement. The aim of this narrative review is to clarify whether shared algorithms exist, allowing them to inform the daily practice in the proper antibiotics posology for critically ill patients undergoing CRRT.
Keywords: antibiotics; pharmacodynamics; pharmacokinetics; renal failure; renal replacement therapy.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.Crit Care. 2014 Jun 23;18(3):227. doi: 10.1186/cc13938. Crit Care. 2014. PMID: 25042938 Free PMC article. Review.
-
The impact of continuous renal replacement therapy on antibiotic pharmacokinetics in critically ill patients.Expert Opin Drug Metab Toxicol. 2021 May;17(5):543-554. doi: 10.1080/17425255.2021.1902985. Epub 2021 Mar 28. Expert Opin Drug Metab Toxicol. 2021. PMID: 33733979 Review.
-
The effect of a loading dose of meropenem on outcomes of patients with sepsis treated by continuous renal replacement: study protocol for a randomized controlled trial.Trials. 2022 Apr 12;23(1):294. doi: 10.1186/s13063-022-06264-2. Trials. 2022. PMID: 35413886 Free PMC article.
-
Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy.Clin Pharmacokinet. 2008;47(3):173-80. doi: 10.2165/00003088-200847030-00003. Clin Pharmacokinet. 2008. PMID: 18307371 Clinical Trial.
-
Acute renal failure in critically ill surgical patients: persistent lethality despite new modes of renal replacement therapy.J Trauma. 2007 Nov;63(5):987-93. doi: 10.1097/TA.0b013e3181574930. J Trauma. 2007. PMID: 17993940
Cited by
-
Drug-Drug Interactions in Nosocomial Infections: An Updated Review for Clinicians.Pharmaceutics. 2024 Aug 28;16(9):1137. doi: 10.3390/pharmaceutics16091137. Pharmaceutics. 2024. PMID: 39339174 Free PMC article. Review.
-
Therapeutic potential of urine-derived stem cells in renal regeneration following acute kidney injury: A comparative analysis with mesenchymal stem cells.World J Stem Cells. 2024 May 26;16(5):525-537. doi: 10.4252/wjsc.v16.i5.525. World J Stem Cells. 2024. PMID: 38817335 Free PMC article.
-
A narrative review on antimicrobial dosing in adult critically ill patients on extracorporeal membrane oxygenation.Crit Care. 2024 Oct 4;28(1):326. doi: 10.1186/s13054-024-05101-z. Crit Care. 2024. PMID: 39367501 Free PMC article. Review.
References
-
- Vincent J.L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas-Chanoin M.H., Hemmer M. EPIC international Advisory Committee. The prevalence of nosocomial infection in intensive care units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA. 1995;274:639–644. doi: 10.1001/jama.1995.03530080055041. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources